BioSpace News Archive

Business

Hyland Healthcare Collaborates with Change Healthcare to Speed and Simplify Claim Attachments for Providers and Payers

Hyland’s workflow and business process management technology, coupled with the Change Healthcare Intelligent Healthcare Network™, help providers slash the time and expense required to submit medical claim attachments

September 12, 2018
·
4 min read
BioCapital

FDA awards five grants to advance the development of pediatric medical devices

The U.S. Food and Drug Administration announced today that it has awarded five grants totaling up to $6 million per year over the next five years to Pediatric Device Consortia (PDC) across the country that will provide advice and support services to innovators of children’s medical devices.

September 12, 2018
·
4 min read
Pharm Country

TrentonMetro LLC in Top-Running to be Central Jersey’s Next Medical Marijuana Operator.

“As Trenton grows, the community knows.”

September 12, 2018
·
5 min read
Biotech Beach

Olympic And Professional Athletes Launch Switch4Good Coalition To Expose Hidden Dairy Epidemic

According to the National Institutes of Health, more than 65 percent of all humans are cow’s milk intolerant.

September 12, 2018
·
5 min read
Business

BIOCAD and SPH Agree to Build a Drug Substance Manufacturing Facility in China

BioCad and Shanghai Pharmaceutical Holding entered into a Memorandum of Understanding to create two joint ventures for production, clinical development, registration, and marketing of several high-cost medicines based on monoclonal antibodies in the People’s Republic of China.

September 12, 2018
·
2 min read
Drug Development

First In Class Immunostimulating Anticancer Agent able to Directly Inhibit Tumor Signaling and Kill Tumor Cells, is in Clinical Trial for Glioblastoma and Melanoma Metastatic to the Brain

In the ongoing challenge to combat the almost always deadly brain cancers, namely Glioblastoma and melanoma metastasized to the brain, the pharmaceutical company Moleculin Biotech, Inc., (Nasdaq: MBRX) has initiated a Phase 1 clinical trial of a new first-in-class cancer drug candidate.

September 12, 2018
·
6 min read
Business

Intermountain Healthcare Now Delivers the Nation’s First “One Stick” Hospitalization for Inpatient Blood Draws

As part of its commitment to transform the patient and caregiver experience while delivering high quality care, Intermountain Healthcare today announced that it is the first integrated health system in the U.S. to implement a new needle-free blood collection system across all of its 22 hospitals.

September 12, 2018
·
3 min read
Policy

Vapor Technology Association Responds To FDA’s Announcement

Today, the Vapor Technology Association responded to the Food & Drug Administration’s announcements regarding the e-cigarette industry.

September 12, 2018
·
2 min read
Policy

CVS Health Applauds FDA’s Steps to Address the Epidemic of Youth Use of Electronic Cigarettes and Vaping Devices

CVS Health today applauded the enforcement actions taken by the U.S. Food and Drug Administration (FDA) to curtail the sale and marketing of e-cigarettes to the nation’s youth.

September 12, 2018
·
3 min read
BioMidwest

It’s For The Kids! Briggs & Stratton Commits $1M To Children’s Hospital

Briggs & Stratton Corporation is pleased to announce its $1 million commitment to Children’s Hospital of Wisconsin, extending its exclusive 23-year title sponsorship of Briggs & Al’s Run & Walk - the hospital’s longest-standing, and one of its most successful, fundraising events - through 2022.

September 12, 2018
·
2 min read